Search research articles
Contact Us
Filters
Showing results (381-390 of 544) with videos related to
Page
of 55
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
September 30, 2004
Synthesis and biological evaluation of thiazolidine-2,4-dione and 2,4-thione derivatives as inhibitors of translation initiation
Han Chen, Yun-Hua Fan, Amarnath Natarajan, et al.
The Journal of Infectious Diseases
|
May 7, 2002
The changing age and seasonal profile of pertussis in Canada
Danuta M Skowronski, Gaston De Serres, Diane MacDonald, et al.
Vaccine
|
October 9, 2013
Applicability of the Brighton Collaboration Case Definition for seizure after immunization in active and passive surveillance in Canada
Karina A Top, Cora M Constantinescu, Julie Laflèche, et al.
Vaccine
|
November 24, 2005
Safety and immunogenicity of a Proteosome -trivalent inactivated influenza vaccine, given nasally to healthy adults
Joanne M Langley, Scott A Halperin, Shelly McNeil, et al.
The Pediatric Infectious Disease Journal
|
October 19, 2016
Do Dose Numbers Matter?: Evaluation of Differing Infant and Toddler Meningococcal C Conjugate Vaccine Programs in Canadian Children
Julie A Bettinger, Otto G Vanderkooi, David W Scheifele, et al.
Nature Medicine
|
December 25, 2007
Rapid conditional targeted ablation of cells expressing human CD59 in transgenic mice by intermedilysin
Weiguo Hu, Sean P Ferris, Rodney K Tweten, et al.
Scandinavian Journal of Infectious Diseases
|
January 1, 1995
Safety and immunogenicity of two acellular pertussis vaccines with different pertussis toxoid and filamentous hemagglutinin content in infants 2-6 months old
S A Halperin, B Eastwood, L Barreto, et al.
Vaccine
|
June 19, 2012
Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adults
Scott A Halperin, Shelly McNeil, Joanne M Langley, et al.
The Pediatric Infectious Disease Journal
|
April 27, 2000
Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults
S A Halperin, B Smith, M Russell, et al.
Journal of Pharmaceutical Policy and Practice
|
October 26, 2016
Impact of pharmacists as immunizers on influenza vaccination coverage in the community-setting in Nova Scotia, Canada: 2013-2015
Jennifer E Isenor, Jessica L Killen, Beverly A Billard, et al.
Page
of 55
Search research articles
Search
Showing results (381-390 of 544) with videos related to
Sort By:
Page
of 55
Bioorganic & Medicinal Chemistry Letters
|
September 30, 2004
Synthesis and biological evaluation of thiazolidine-2,4-dione and 2,4-thione derivatives as inhibitors of translation initiation
Han Chen, Yun-Hua Fan, Amarnath Natarajan, et al.
The Journal of Infectious Diseases
|
May 7, 2002
The changing age and seasonal profile of pertussis in Canada
Danuta M Skowronski, Gaston De Serres, Diane MacDonald, et al.
Vaccine
|
October 9, 2013
Applicability of the Brighton Collaboration Case Definition for seizure after immunization in active and passive surveillance in Canada
Karina A Top, Cora M Constantinescu, Julie Laflèche, et al.
Vaccine
|
November 24, 2005
Safety and immunogenicity of a Proteosome -trivalent inactivated influenza vaccine, given nasally to healthy adults
Joanne M Langley, Scott A Halperin, Shelly McNeil, et al.
The Pediatric Infectious Disease Journal
|
October 19, 2016
Do Dose Numbers Matter?: Evaluation of Differing Infant and Toddler Meningococcal C Conjugate Vaccine Programs in Canadian Children
Julie A Bettinger, Otto G Vanderkooi, David W Scheifele, et al.
Nature Medicine
|
December 25, 2007
Rapid conditional targeted ablation of cells expressing human CD59 in transgenic mice by intermedilysin
Weiguo Hu, Sean P Ferris, Rodney K Tweten, et al.
Scandinavian Journal of Infectious Diseases
|
January 1, 1995
Safety and immunogenicity of two acellular pertussis vaccines with different pertussis toxoid and filamentous hemagglutinin content in infants 2-6 months old
S A Halperin, B Eastwood, L Barreto, et al.
Vaccine
|
June 19, 2012
Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adults
Scott A Halperin, Shelly McNeil, Joanne M Langley, et al.
The Pediatric Infectious Disease Journal
|
April 27, 2000
Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults
S A Halperin, B Smith, M Russell, et al.
Journal of Pharmaceutical Policy and Practice
|
October 26, 2016
Impact of pharmacists as immunizers on influenza vaccination coverage in the community-setting in Nova Scotia, Canada: 2013-2015
Jennifer E Isenor, Jessica L Killen, Beverly A Billard, et al.
Page
of 55